Skip to main content

Summary Judgment Awarded To UCC In Asbestos Case

Summary Judgment Awarded To UCC In Asbestos Case

Summary Judgment Awarded To UCC In Asbestos Case

Introduction

The Delaware trial court awarded summary judgment to Union Carbide Corp. over an asbestos lawsuit filed against it after finding that the chemical company relied on Georgia-Pacific to warn the end-users for its joint compound products that included Union Carbide’s Calidria asbestos.

The plaintiff purchased and used a joint compound product containing an asbestos product known as Calidria, manufactured by UCC, on multiple occasions between 1971 and 1982. He was diagnosed with lung cancer in 2016 and died later. His wife filed a lawsuit against UCC, alleging that the defendants failed to warn about hazards associated with Calidria, and she also sought relief under the Ohio statue which provided strict liability for defectively formulated products.

UCC filed for summary judgment stating that it provided warnings to Georgia-Pacific. The court found that the defendants relied on Georgia-Pacific to provide warnings to the purchasers of its joint compounds, so the summary judgment was granted in favor of UCC on the claim.

In the U.S., the earliest known asbestos-related lawsuit was filed by a woman in 1929 in the Newark (NJ) Federal Court. Along with her, at least 15 other individuals with asbestos-related claims were trying to get compensation. Unfortunately, the woman's lawsuit was thrown out in 1934, but it brought forth the wave of many such lawsuits. One of the biggest companies targeted by these lawsuits was Johns-Manville Corporation, which filed for bankruptcy in 1982.

J&J is also facing similar lawsuits, each raising a common allegation that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!